Correlation Between NewAmsterdam Pharma and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on NewAmsterdam Pharma and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Mineralys Therapeutics,.
Diversification Opportunities for NewAmsterdam Pharma and Mineralys Therapeutics,
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NewAmsterdam and Mineralys is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Mineralys Therapeutics,
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 1.02 times more return on investment than Mineralys Therapeutics,. However, NewAmsterdam Pharma is 1.02 times more volatile than Mineralys Therapeutics, Common. It trades about 0.11 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.05 per unit of risk. If you would invest 1,913 in NewAmsterdam Pharma on August 28, 2024 and sell it today you would earn a total of 192.00 from holding NewAmsterdam Pharma or generate 10.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Mineralys Therapeutics, |
NewAmsterdam Pharma and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Mineralys Therapeutics,
The main advantage of trading using opposite NewAmsterdam Pharma and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. HCW Biologics | NewAmsterdam Pharma vs. Scpharmaceuticals | NewAmsterdam Pharma vs. Milestone Pharmaceuticals |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |